BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 31703155)

  • 41. Radiomics-based machine learning analysis and characterization of breast lesions with multiparametric diffusion-weighted MR.
    Sun K; Jiao Z; Zhu H; Chai W; Yan X; Fu C; Cheng JZ; Yan F; Shen D
    J Transl Med; 2021 Oct; 19(1):443. PubMed ID: 34689804
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MRI index lesion radiomics and machine learning for detection of extraprostatic extension of disease: a multicenter study.
    Cuocolo R; Stanzione A; Faletti R; Gatti M; Calleris G; Fornari A; Gentile F; Motta A; Dell'Aversana S; Creta M; Longo N; Gontero P; Cirillo S; Fonio P; Imbriaco M
    Eur Radiol; 2021 Oct; 31(10):7575-7583. PubMed ID: 33792737
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Voxel-based supervised machine learning of peripheral zone prostate cancer using noncontrast multiparametric MRI.
    Gholizadeh N; Simpson J; Ramadan S; Denham J; Lau P; Siddique S; Dowling J; Welsh J; Chalup S; Greer PB
    J Appl Clin Med Phys; 2020 Oct; 21(10):179-191. PubMed ID: 32770600
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Radiomic features for prostate cancer detection on MRI differ between the transition and peripheral zones: Preliminary findings from a multi-institutional study.
    Ginsburg SB; Algohary A; Pahwa S; Gulani V; Ponsky L; Aronen HJ; Boström PJ; Böhm M; Haynes AM; Brenner P; Delprado W; Thompson J; Pulbrock M; Taimen P; Villani R; Stricker P; Rastinehad AR; Jambor I; Madabhushi A
    J Magn Reson Imaging; 2017 Jul; 46(1):184-193. PubMed ID: 27990722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prediction of Gleason score in prostate cancer patients based on radiomic features of transrectal ultrasound images.
    Cheng T; Li H
    Br J Radiol; 2024 Feb; 97(1154):415-421. PubMed ID: 38308030
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The potential of prostate gland radiomic features in identifying the Gleason score.
    Gong L; Xu M; Fang M; He B; Li H; Fang X; Dong D; Tian J
    Comput Biol Med; 2022 May; 144():105318. PubMed ID: 35245698
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radiomics-Based Machine Learning Classification for Glioma Grading Using Diffusion- and Perfusion-Weighted Magnetic Resonance Imaging.
    Hashido T; Saito S; Ishida T
    J Comput Assist Tomogr; 2021 Jul-Aug 01; 45(4):606-613. PubMed ID: 34270479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Clinical application of machine learning models in patients with prostate cancer before prostatectomy.
    Guerra A; Orton MR; Wang H; Konidari M; Maes K; Papanikolaou NK; Koh DM
    Cancer Imaging; 2024 Feb; 24(1):24. PubMed ID: 38331808
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Performance of apparent diffusion coefficient values and ratios for the prediction of prostate cancer aggressiveness across different MRI acquisition settings.
    Karaarslan E; Altan Kus A; Alis D; Karaarslan UC; Saglican Y; Argun OB; Kural AR
    Diagn Interv Radiol; 2022 Jan; 28(1):12-20. PubMed ID: 35142611
    [TBL] [Abstract][Full Text] [Related]  

  • 50. High spatiotemporal resolution dynamic contrast-enhanced MRI improves the image-based discrimination of histopathology risk groups of peripheral zone prostate cancer: a supervised machine learning approach.
    Winkel DJ; Breit HC; Block TK; Boll DT; Heye TJ
    Eur Radiol; 2020 Sep; 30(9):4828-4837. PubMed ID: 32328763
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer.
    Montoya Perez I; Merisaari H; Jambor I; Ettala O; Taimen P; Knaapila J; Kekki H; Khan FL; Syrjälä E; Steiner A; Syvänen KT; Verho J; Seppänen M; Rannikko A; Riikonen J; Mirtti T; Lamminen T; Saunavaara J; Falagario U; Martini A; Pahikkala T; Pettersson K; Boström PJ; Aronen HJ
    J Magn Reson Imaging; 2022 Feb; 55(2):465-477. PubMed ID: 34227169
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Discriminating malignant from benign testicular masses using machine-learning based radiomics signature of appearance diffusion coefficient maps: Comparing with conventional mean and minimum ADC values.
    Fan C; Sun K; Min X; Cai W; Lv W; Ma X; Li Y; Chen C; Zhao P; Qiao J; Lu J; Guo Y; Xia L
    Eur J Radiol; 2022 Mar; 148():110158. PubMed ID: 35066342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Utility of radiomic zones for risk classification and clinical outcome predictions using supervised machine learning during simultaneous
    Tu SJ; Tran VT; Teo JM; Chong WC; Tseng JR
    Med Phys; 2021 Sep; 48(9):5192-5201. PubMed ID: 34214211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
    Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
    Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rotating frame relaxation imaging of prostate cancer: Repeatability, cancer detection, and Gleason score prediction.
    Jambor I; Pesola M; Taimen P; Merisaari H; Boström PJ; Minn H; Liimatainen T; Aronen HJ
    Magn Reson Med; 2016 Jan; 75(1):337-44. PubMed ID: 25733132
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Radiomic Machine Learning for Characterization of Prostate Lesions with MRI: Comparison to ADC Values.
    Bonekamp D; Kohl S; Wiesenfarth M; Schelb P; Radtke JP; Götz M; Kickingereder P; Yaqubi K; Hitthaler B; Gählert N; Kuder TA; Deister F; Freitag M; Hohenfellner M; Hadaschik BA; Schlemmer HP; Maier-Hein KH
    Radiology; 2018 Oct; 289(1):128-137. PubMed ID: 30063191
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Radiomics analysis of 18F-Choline PET/CT in the prediction of disease outcome in high-risk prostate cancer: an explorative study on machine learning feature classification in 94 patients.
    Alongi P; Stefano A; Comelli A; Laudicella R; Scalisi S; Arnone G; Barone S; Spada M; Purpura P; Bartolotta TV; Midiri M; Lagalla R; Russo G
    Eur Radiol; 2021 Jul; 31(7):4595-4605. PubMed ID: 33443602
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Radiomic Features From Diffusion-Weighted MRI of Retroperitoneal Soft-Tissue Sarcomas Are Repeatable and Exhibit Change After Radiotherapy.
    Thrussell I; Winfield JM; Orton MR; Miah AB; Zaidi SH; Arthur A; Thway K; Strauss DC; Collins DJ; Koh DM; Oelfke U; Huang PH; O'Connor JPB; Messiou C; Blackledge MD
    Front Oncol; 2022; 12():899180. PubMed ID: 35924167
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Longitudinal acquisition repeatability of MRI radiomics features: An ACR MRI phantom study on two MRI scanners using a 3D T1W TSE sequence.
    Wong OL; Yuan J; Zhou Y; Yu SK; Cheung KY
    Med Phys; 2021 Mar; 48(3):1239-1249. PubMed ID: 33370474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Calculation of Apparent Diffusion Coefficients in Prostate Cancer Using Deep Learning Algorithms: A Pilot Study.
    Hu L; Zhou DW; Fu CX; Benkert T; Xiao YF; Wei LM; Zhao JG
    Front Oncol; 2021; 11():697721. PubMed ID: 34568027
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.